Changeflow GovPing Pharma & Drug Safety Intraocular Lens Podeye Safety Notice - Field S...
Routine Notice Added Final

Intraocular Lens Podeye Safety Notice - Field Safety Notice R2610293

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

ANSM has informed health establishments of a safety action implemented by the company Physiol/BVI regarding Podeye intraocular lenses. The safety action is registered under reference number R2610293. Health establishments concerned by this action should review the attached letter from Physiol/BVI dated 14/04/2026.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

ANSM has recorded a safety action under reference R2610293 initiated by the medical device manufacturer Physiol/BVI concerning Podeye intraocular lenses. The field safety notice from the company dated 14/04/2026 is attached to this notification.

Health establishments that may have received or used the affected Podeye lenses should review the manufacturer's letter to determine if any follow-up actions or patient monitoring is required. Healthcare providers should ensure relevant clinical staff are aware of this safety information.

What to do next

  1. Review the letter from Physiol/BVI regarding Podeye intraocular lenses
  2. Ensure affected health establishments have received and reviewed the field safety notice
  3. Contact Physiol/BVI directly for questions regarding this safety action

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2610293 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Physiol/BVI.
Les établissements de santé concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2610293.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Physiol/BVI (14/04/2026)

Named provisions

Information n° R2610293 destinée aux établissements de santé

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
April 14th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
R2610293
Docket
R2610293

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device safety Patient notification Field safety corrective action
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Public Health

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!